WHYZE Health leverages an innovative AI-driven platform to transform Real-World Evidence (RWE) into actionable improved patient health outcomes
Company Name: WHYZE Health Ltd
Problem Area: Longevity, Healthspan, and Wellness - Startups addressing physical or mental health challenges, fitness, or late-life happiness. Example: Telemedicine platforms, mental health apps, or fitness tech.
Company URL: https://www.whyzehealth.com/
Primary Industry: Health Tech & Medicine
Business Model: B2B SaaS
Funding Stage: Seed
Company Stage: Ready to Sell
Recent Traction: Most Noticeable Recent Traction WHYZE Health is building strong momentum across investment, partnerships, and commercial traction: • Strategic Investment & Commercial Partnership: Mayo Clinic joined our cap table and is also our commercial partner in the US, validating WHYZE’s model with one of the world’s most respected healthcare institutions. • Funding & Grants: Secured a $500k partner grant from AWS and InterSystems, strengthening our technology and scalability roadmap. • Customer Wins: Signed our first four customer contracts with Bdd Pharm, Clerkenwell Health, AbbVie, and CRP Ireland, demonstrating rapid commercial adoption. • Expansion: In the final stages of closing a county-wide rollout in the Wales, positioning WHYZE for scaled NHS impact. • Product Launch: Preparing for our UK product launch in October 2025, marking a key inflection for growth and broader market penetration. • Industry Validation: Elligo Health Inc. investment and partnership further reinforces WHYZE as the preferred AI-driven RWE partner across the US and EU. Together, these milestones demonstrate that WHYZE is converting partnerships and technology leadership into commercial traction and scalable healthcare impact.